Radiation Applications

Nuclear Medicine / Framatome And Nuclearelectrica Begin Lu-177 ‘Implementation Phase’ At Cernavodă

By David Dalton
15 October 2024

Full-scale irradiation service at Candu reactor could begin in 2028

Framatome And Nuclearelectrica Begin Lu-177 ‘Implementation Phase’ At Cernavodă
The project could see Cernavodă-2 producing the vital radioisotope for cancer treatment.
French nuclear company Framatome and Romanian state nuclear operator Nuclearelectrica have begun the implementation phase of a project to produce the medical radioisotope lutetium-177 (Lu-177) at the Cernavodă nuclear power station in Romania.

Want to know more?
Sign up.

Pen Use this content

Tags


Related